Selected Grants
Exploitation of a new targetable node in the AR signaling pathway in prostate cancer
ResearchLab Research Analyst I · Awarded by Department of Defense · 2022 - 2025CaMKK2 inhibition as an approach to increase tumor immunity in breast cancers
ResearchResearch Technician II · Awarded by Department of Defense · 2020 - 2024Evaluation of SGK as a therapeutic target in models of breast and prostate cancer
ResearchLab Research Analyst I · Awarded by LQT Therapeutics · 2021 - 2022External Relationships
- Adara Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.